Opiates include morphine, heroin, codeine, meperidine, and hydromorphone. Heroin is only available illegally in the United States. Opiates are commonly used for pain control.
Opiate use and abuse are relatively uncommon in the United States. Lifetime prevalence in 1991 was 0.9% and point prevalence was less than 0.1 %, although more recent surveys indicate opiate use and abuse has been increasing during the past decade. Many of those who use opiates recreationally become addicted. The number of opiate addicts in the United States is estimated at 500,000.
History, Physical and Mental Status
Examinations, and Laboratory Tests
Most heroin and morphine users take opiates intravenously, which produces flushing and an intensely pleasurable, diffuse bodily sensation that resembles orgasm. This initial “rush” is followed by a sense of well-being. Psychomotor retardation, drowsiness, inactivity, and impaired concentration ensue. Signs of intoxication occur immediately after the addict “shoots up” and include pupillary constriction, respiratory depression, slurred speech, hypotension, bradycardia, and hypothermia. Nausea, vomiting, and constipation are common after opiate use. Opiate use can be confirmed by urine or serum toxicologic measurements.
Opiate abuse is defined by the criteria for substance abuse noted above. In opiate dependence, tolerance to the effects of opiates occurs. Addicts “shoot up” three or more times per day.
Withdrawal symptoms usually begin 10 hours after the last dose. Withdrawal from opiates can be highly uncomfortable but is rarely medically complicated or life-threatening. Withdrawal symptoms are listed in Table 5-2.
Opiate addicts often have comorbid substance use disorders, antisocial or borderline personality disorders, and mood disorders. Opiate addicts are more prone to commit crimes because of the high cost of opiates. Opiate addiction also is associated with high mortality rates from inadvertent overdoses, accidents, and suicide. Opiate addicts are also at higher risk of medical problems because of poor nutrition and use of dirty needles. Common medical disorders include serum hepatitis, HIV infection, endocarditis, pneumonia, and cellulitis.
The diagnosis of opiate addiction is usually obvious after a careful history and mental status and physical examinations.
Patients addicted to opiates should be gradually withdrawn using methadone. Methadone is a weak agonist of the mu opiate receptor and has a longer half-life (15 hours) than heroin or morphine. Thus, it causes relatively few intoxicant or withdrawal effects. Generally, the initial dose of methadone (typically 5-20mg) is based on the profile of withdrawal symptoms. Withdrawal from short-acting opiates lasts 7 to 10 days; withdrawal from longer-acting meperidine lasts 2 to 3 weeks.
Clonidine, a centrally acting alpha 2 receptor agonist that decreases central noradrenergic output, can also be used for acute withdrawal syndromes. It is remarkably effective at treating the autonomic symptoms of withdrawal but does little to curb the drug craving. Risks of sedation and hypotension limit clonidine’s usefulness in outpatient settings.
Additional medications can be used to relieve uncomfortable symptoms of withdrawal, such as dicyclomine for abdominal cramping, promethazine for nausea, and quinine for muscle aches.
Rehabilitation generally involves referral to an intensive day treatment program and to Narcotics Anonymous, a 12-step program similar to AA. Methadone maintenance, daily administration of 60-100mg of methadone in government-licensed methadone clinics, is used widely for patients with demonstrated physiologic dependence. Long-term administration of methadone can alleviate drug hunger and minimize drug-seeking behavior.
1. Recreational use of opiates often leads to addiction.
2. Opiate addicts are at increased risk of HIV, pneumonia, endocarditis, hepatitis, and cellulitis.
3. High mortality occurs from accidental overdose, suicide, and accidents.
4. Opiate withdrawal begins 10 hours after last dose.
5. Withdrawal is uncomfortable but not usually medically complicated.
Revision date: July 3, 2011
Last revised: by Janet A. Staessen, MD, PhD